Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group
  2. Taxonomy
  3. Term
  4. Neuroscience

Participant treatment assignment perceptions in the NIDA CTN cocaine use reduction with buprenorphine study

Go back to Resources

Participant treatment assignment perceptions in the NIDA CTN cocaine use reduction with buprenorphine study

Authors:

Volume:

Pagination:

Journal:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Procurement and Distribution of Study Medicines

Go back to Resources

Procurement and Distribution of Study Medicines

Authors:

Secondary:

Publisher:

Editor(s):

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Best practices for study drug management and accountability throughout the study lifecycle in multi-site randomized controlled trials

Go back to Resources

Best practices for study drug management and accountability throughout the study lifecycle in multi-site randomized controlled trials

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Tailoring a comprehensive website to support a clinical research network

Go back to Resources

Tailoring a comprehensive website to support a clinical research network

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

The training documentation form-Going beyond the basics for the national institute on drug abuse (NIDA) national drug abuse treatment clinical trials network (CTN)

Go back to Resources

The training documentation form-Going beyond the basics for the national institute on drug abuse (NIDA) national drug abuse treatment clinical trials network (CTN)

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial

Go back to Resources

Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial

Authors:

Pagination:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial

Go back to Resources

Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial

Go back to Resources

Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial

Authors:

Volume:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment

Go back to Resources

Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal

Go back to Resources

Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • Previous page ‹‹
  • Page 5
  • Next page ››
Subscribe to Neuroscience
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification